Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017

Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017

Since 2006, some Italian Regions introduced the active offer of measles, mumps, rubella, and varicella (MMRV) vaccine for all newborns during the second years of life. In 2011, Italian Drug Authority (AIFA) recommended the discontinuation of the MMRV use for an increased risk of febrile seizures fol...

Full description

Bibliographic Details
Main Authors: Pasquale Stefanizzi, Sara De Nitto, Francesco Patano, Francesco Paolo Bianchi, Davide Ferorelli, Paolo Stella, Domenica Ancona, Vito Bavaro, Silvio Tafuri
Format: Article
Language:English
Published: Taylor & Francis Group 2020-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
vaccine safety
febrile seizures
causality assessment
pharmacovigilance
adverse events following immunization
Online Access:http://dx.doi.org/10.1080/21645515.2019.1704124

Internet

http://dx.doi.org/10.1080/21645515.2019.1704124

Similar Items